Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Upper Extremity Implants Market, by Material
1.4.2 LAMEA Upper Extremity Implants Market, by Type
1.4.3 LAMEA Upper Extremity Implants Market, by End-use
1.4.4 LAMEA Upper Extremity Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Mergers & Acquisition
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals and Trials
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Jun – 2023, May) Leading Players
Chapter 4. LAMEA Upper Extremity Implants Market by Material
4.1 LAMEA Metallic Biomaterials Market by Country
4.2 LAMEA Ceramic Biomaterials Market by Country
4.3 LAMEA Polymeric Biomaterials Market by Country
4.4 LAMEA Natural Biomaterials Market by Country
Chapter 5. LAMEA Upper Extremity Implants Market by Type
5.1 LAMEA Shoulder Market by Country
5.2 LAMEA Elbow Market by Country
5.3 LAMEA Hand & Wrist Market by Country
Chapter 6. LAMEA Upper Extremity Implants Market by End-use
6.1 LAMEA Hospitals Market by Country
6.2 LAMEA Clinics Market by Country
6.3 LAMEA ASCs' Market by Country
Chapter 7. LAMEA Upper Extremity Implants Market by Country
7.1 Brazil Upper Extremity Implants Market
7.1.1 Brazil Upper Extremity Implants Market by Material
7.1.2 Brazil Upper Extremity Implants Market by Type
7.1.3 Brazil Upper Extremity Implants Market by End-use
7.2 Argentina Upper Extremity Implants Market
7.2.1 Argentina Upper Extremity Implants Market by Material
7.2.2 Argentina Upper Extremity Implants Market by Type
7.2.3 Argentina Upper Extremity Implants Market by End-use
7.3 UAE Upper Extremity Implants Market
7.3.1 UAE Upper Extremity Implants Market by Material
7.3.2 UAE Upper Extremity Implants Market by Type
7.3.3 UAE Upper Extremity Implants Market by End-use
7.4 Saudi Arabia Upper Extremity Implants Market
7.4.1 Saudi Arabia Upper Extremity Implants Market by Material
7.4.2 Saudi Arabia Upper Extremity Implants Market by Type
7.4.3 Saudi Arabia Upper Extremity Implants Market by End-use
7.5 South Africa Upper Extremity Implants Market
7.5.1 South Africa Upper Extremity Implants Market by Material
7.5.2 South Africa Upper Extremity Implants Market by Type
7.5.3 South Africa Upper Extremity Implants Market by End-use
7.6 Nigeria Upper Extremity Implants Market
7.6.1 Nigeria Upper Extremity Implants Market by Material
7.6.2 Nigeria Upper Extremity Implants Market by Type
7.6.3 Nigeria Upper Extremity Implants Market by End-use
7.7 Rest of LAMEA Upper Extremity Implants Market
7.7.1 Rest of LAMEA Upper Extremity Implants Market by Material
7.7.2 Rest of LAMEA Upper Extremity Implants Market by Type
7.7.3 Rest of LAMEA Upper Extremity Implants Market by End-use
Chapter 8. Company Profiles
8.1 Stryker Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Geographical Expansions:
8.2 DePuy Synthes (Johnson & Johnson)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental & Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.3 Zimmer Biomet Holdings, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Smith & Nephew PLC
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional and Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Medtronic PLC
8.5.1 Company overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals & Trials:
8.5.5.2 Mergers & Acquisitions:
8.5.6 SWOT Analysis
8.6 Aesculap, Inc. (B. Braun Melsungen AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.7 DJO Global (Enovis Corporation)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Ossur Hf.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Acumed LLC (Colson Medical, Inc.)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.10. Arthrex, Inc.
8.10.1 Company Overview
Unique Offerings 